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The genetic basis for chronic persistence of Brucella abortus in lymphoid organs of mice, cows, and humans
is currently unknown. We identified B. abortus genes involved in chronic infection, by assessing the ability of
178 signature-tagged mutants to establish and maintain persistent infection in mice. Each mutant was
screened for its ability to colonize the spleens of mice at 2 and 8 weeks after inoculation. Comparison of the
results from both time points identified two groups of mutants attenuated for chronic infection in mice. The
first group was not recovered at either 2 or 8 weeks postinfection and was therefore defective in establishing
infection. Mutants in this group carried transposon insertions in genes involved in lipopolysaccharide bio-
synthesis (wbkA), in aromatic amino acid biosynthesis, and in type IV secretion (virB1 and virB10). The second
group, which was recovered at wild-type levels 2 weeks postinfection but not 8 weeks postinfection was able to
establish infection but was unable to maintain chronic infection. One mutant in this group carried a trans-
poson insertion in a gene with homology to gcvB of Mycobacterium tuberculosis, encoding glycine dehydrogenase,
an enzyme whose activity is increased during the state of nonreplicating persistence. These results suggest that
some mechanisms for long-term persistence may be shared among chronic intracellular pathogens. Further-
more, identification of two groups of genes, those required for initiating infection and those required only for
long-term persistence, suggests that B. abortus uses distinct sets of virulence determinants to establish and
maintain chronic infection in mice.
Bacteria causing chronic infections, such as Mycobacterium
tuberculosis, Chlamydia trachomatis, and Brucella abortus are
able to evade the host’s immune system throughout the infec-
tion by colonizing an intracellular niche. This lifestyle may
require adaptations other than the brief survival in phagocytic
cells observed for well-characterized intracellular pathogens
such as Salmonella serotypes which cause an acute infection.
While M. tuberculosis and C. trachomatis are difficult to ma-
nipulate genetically, the genetic manipulation of the Brucella
genome can be performed routinely, using tools such as plas-
mid vectors and systems for Tn5 mutagenesis (20–22). Thus,
identification of the genes required by B. abortus to cause
infection may reveal virulence mechanisms of chronic disease
caused by other intracellular pathogens. A recent improve-
ment in Tn5 mutagenesis, known as signature-tagged transpo-
son mutagenesis (STM), has been developed for the in vivo
selection of Tn5 mutants that are defective in colonization
(18). This method uses experimentally infected animals to
identify mutants that are attenuated in vivo from a large, mixed
pool of mutants (29). Since Tn5 can be used in B. abortus, STM
can be used to identify genes that are necessary for chronic
intracellular infection.
Brucellosis is endemic in Mediterranean countries and Cen-
tral and South America and is manifested as an undulant fever
in humans that, if untreated, can develop into a chronic infec-
tion with symptoms persisting for several months (32). Chronic
infections may result in infection of secondary tissues, includ-
ing heart and brain, if the infection is left untreated. Symptoms
may also recur years after the original infection. B. abortus
infection is acquired by humans through contact with infected
livestock and consumption of unpasteurized dairy products.
Bacteria cause a systemic infection and localize preferentially
to organs that are rich in elements of the reticuloendothelial
system, such as liver, spleen, and lymph nodes, where they
survive and multiply within host macrophages. B. abortus has
been found to inhibit the bactericidal functions of phagocytes,
including phagolysosomal fusion, neutrophil degranulation,
and the oxidative burst (5); however, as with other intracellular
pathogens which cause chronic infection, the genetic basis for
the interaction of Brucella with phagocytic cells is still poorly
understood. B. abortus virulence is conveniently studied in a
mouse model that mimics the chronic infection observed in
humans. Here bacteria are found intracellularly, within mac-
rophages of infected organs (25). Experimental infection of
BALB/c mice has shown that the infection has two phases:
during the first 2 weeks, bacteria multiply rapidly. In the sec-
ond phase, bacterial numbers stabilize over the next 5 to 6
weeks and then decrease slowly. Bacteria have been recovered
from spleens of infected mice as late as 24 weeks postinfec-
tion (26, 28). The different phases of B. abortus infection in
mice raise the question whether this pathogen uses different
sets of virulence genes during the early and late stages of this
disease.
To address this question, we have performed a random
screen of the genome of B. abortus to identify genes required
for infection at an early (2 weeks postinfection) and a late (8
weeks postinfection) time point postinoculation. Comparative
analysis of these results provided new insight into the genetic
basis for chronic intracellular infection and B. abortus patho-
genesis. Furthermore, our results suggest that a better under-
standing of the mechanisms by which B. abortus is able to cause
chronic intracellular infection may ultimately reveal strategies
that are shared by other, less tractable pathogens.
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Construction of mutants and growth conditions. B. abortus strain 2308 (ob-
tained from B. L. Deyoe, National Animal Disease Center, Ames, Iowa) was
used as a host for STM. A bank comprising 240 signature-tagged B. abortus
mutants (ST mutants) was constructed using a pool containing 10,000 uniquely
tagged miniTn5Km2 derivatives carried on suicide plasmids, which was obtained
from David Holden (18). The transposons were introduced into B. abortus S2308
by electroporation and selected on tryptic soy agar (TSA; Difco) containing 100
mg of kanamycin (Km) per liter (1). Approximately 20 mutants were taken from
each of 10 individual electroporations in order to minimize the isolation of
siblings. Mutants resistant to ampicillin were eliminated from the pool, since they
carry the suicide vector inserted into the chromosome. For infection of mice,
B. abortus strains were grown on potato infusion agar (PIA; Difco) for 48 h and
resuspended at the appropriate concentration in phosphate-buffered saline
(PBS) (2). For determination of auxotrophy, the chemically defined solid me-
dium formulated by Gerhardt was used, which contains glycerol, glutamate,
lactate, thiamine, nicotinic acid, biotin, calcium pantothenate, and inorganic salts
(15). This basal medium was supplemented with 10 groups of amino acids to
perform auxanography for attenuated mutants. All work with live B. abortus was
performed in a biosafety level 3 containment facility following Centers for Dis-
ease Control-National Institutes of Health guidelines.
Infection of mice. For the mutant screen, pools of 46 mutants were used to
infect groups of six 6- to 8-week-old BALB/c mice intraperitoneally (i.p.) at a
total dose of approximately 106 CFU. Groups of three mice were sacrificed at 2
and at 8 weeks postinfection, and bacteria were recovered from the spleens.
Spleens were homogenized in 3 ml of PBS, and serial 10-fold dilutions were
plated on TSA-Km.
Signature-tagged screen and hybridization analysis. Bacteria recovered from
murine spleens at 2 and 8 weeks postinfection were pooled to obtain one output
pool from each mouse. Total chromosomal DNA was prepared from each output
pool to serve as a template for generating probes containing labeled tags, as
described before (18). Labeled tags used as probes were prepared by incorpo-
ration of [a-32P]dATP during PCR amplification of tags from total chromosomal
DNA. Blots containing chromosomal DNA from individual mutants in each pool
were prepared by transferring pools of B. abortus ST mutants from 96-well plates
onto nylon membranes laid on top of TSA plates with a 48-prong replicator.
Hybridization and washes were carried out under stringent conditions (4). To
identify potentially attenuated mutants, hybridization signals on a blot probed
with labeled tags prepared from the input pool (inoculum) were compared with
three identical blots hybridized with tags prepared from the output pools recov-
ered from the three mouse spleens at each time point. Mutants giving a hybrid-
ization signal with the input pool but no signal in the output pool of at least two
mice were selected for further study. To confirm that each mutant carried a
single insertion of mini-Tn5 in the chromosome, mutants were analyzed by
Southern blot (4). Chromosomal DNA was prepared (4) and digested with
EcoRI, which cuts once within the transposon, outside the kanamycin resistance
gene. After agarose gel electrophoresis and transfer to nylon membranes, chro-
mosomal DNA was analyzed by hybridization with a probe containing a 1.3-kb
fragment of the Tn903 kanamycin resistance gene from plasmid pUC4KSAC
(Pharmacia). Mutants whose chromosomal DNA gave a hybridization signal with
a single band on the Southern blot were determined to have only one copy of the
transposon inserted into the chromosome.
Competitive infection assay. For competitive infection experiments, groups of
four mice were inoculated i.p. with an approximately 1:1 mixture of mutant and
wild-type B. abortus, at a total dose of approximately 105 CFU. Mice were
sacrificed at 2 or 8 weeks postinfection, and bacteria were recovered from
infected spleens. The CFU of mutant and wild-type B. abortus recovered from
infected spleens were enumerated by serial dilution in PBS and plating in parallel
on TSA and TSA-Km. Numbers of wild-type and mutant bacteria were calcu-
lated by subtracting the CFU recovered on TSA-Km, on which only the Tn5
mutants are able to grow, from the CFU recovered on TSA plates, representing
the total number of bacteria recovered. Data were normalized by dividing the
output ratio of (CFU [wild type]/CFU [mutant]) by the input ratio of (CFU [wild
type]/CFU [mutant]). All data were then converted logarithmically for statistical
analysis. A Student’s t test was used to determine whether the wild-type/mutant
ratio recovered from infected spleens was significantly different from the wild-
type/mutant ratio present in the challenge inoculum.
Cloning and sequence analysis. Transposon-flanking DNA was cloned by
inverse PCR as described previously (6) using RsaI for digestion of chromosomal
DNA and the primer pair SIGN-10 (59-GCCGAACTTGTGTATAAGAGTCA
G-39) and SIGN-11 (59-AAAGGTAGCGTTGCCAATG-39). The PCR products
were ligated into cloning vector pCR II (Invitrogen), and plasmid DNA for
sequencing was isolated from Escherichia coli strain DH5a (17) using ion-ex-
change columns from Qiagen. In addition, larger DNA fragments flanking the
transposon insertions in several of the mutants were cloned by ligating PstI- or
EcoRI-restricted genomic DNA into cloning vector pBluescript SK1 restricted
with the appropriate enzyme and selection for the kanamycin resistance marker
of mini-Tn5Km2 (12). Nucleotide sequences were analyzed using the MacVector
6.5 software package (Oxford Molecular Group). Sequence homology was de-
termined using the BLAST2 search algorithm at the National Center for Bio-
technology Information (NCBI) (3).
RESULTS
Generation of signature-tagged mutants of B. abortus. B. abor-
tus 2308 was mutagenized with a pool of signature-tagged mini-
Tn5Km2 derivatives carried on plasmid pUT by electropora-
tion, and mutants were selected on TSA-Km. These mutants
were screened for susceptibility to ampicillin to eliminate strains
(fewer than 2% of mutants) carrying cointegrates of the suicide
vector pUT inserted in the chromosome. To confirm that mu-
tants obtained from the same electroporation are not siblings
but arise from independent transposition events, Southern hy-
bridization was performed using the 1.3-kb EcoRI fragment of
pUC4KSAC, which contains the Tn903 Kmr gene (12). Using
this probe, the hybridization profiles of EcoRI-digested chro-
mosomal DNA from 10 randomly chosen mutants from a sin-
gle electroporation were compared. Since EcoRI cuts only once
within miniTn5Km2, a mutant with a single transposon inser-
tion should have only one band hybridizing with the probe. All
of the mutants examined had a single band of unique size
hybridizing with the probe, indicating that each mutant con-
tained a single, unique insertion of the transposon (data not
shown).
Signature-tagged screen of B. abortus mutants in mice. To
identify mutants defective in establishing chronic infection, we
used the BALB/c mouse model of chronic brucellosis. Mice
infected i.p. with B. abortus have been shown to harbor bacte-
ria in the spleen for up to 24 weeks postinfection (5, 9). The
persistence of B. abortus in mice is similar to chronic infection
observed in other host species, including humans.
It has not been shown whether attenuated B. abortus mu-
tants exhibit competitive infection defects in mice when
coinoculated with a virulent strain. We therefore performed
a preliminary competitive infection experiment using B. abor-
tus 2308 and CA180, a Tn5 mutant defective in the synthesis of
the O antigen of lipopolysaccharide (LPS), which was charac-
terized previously (1). Three mice were infected i.p. with a
mixture containing 6.4 3 104 CFU of B. abortus 2308 and 4.1 3
104 CFU of CA180. At 1 week postinfection, no mutant B.
abortus could be recovered from the spleens of any infected
mouse, while the number of wild-type B. abortus ranged from
6 3 103 to 2 3 106 CFU/spleen. This result showed that a
mutant with a defect in a known B. abortus virulence factor,
LPS, exhibits a competitive infection defect in the BALB/c
mouse model of brucellosis. Furthermore, it suggested that
STM, which utilizes competitive infection as the basis for
screening pools of mutants, could be used to screen for mu-
tants defective in chronic infection.
For the screen in mice, pools of 46 mutants were grown
individually in tryptic soy broth (TSB) in 96-well plates for 48 h
and then stamped with a 48-prong replicator onto PIA plates
and grown for 48 h. Bacteria were resuspended from PIA
plates, and the concentration was adjusted to approximately
107 CFU/ml with PBS. Of this suspension, 0.1 ml was injected
i.p. into each of six BALB/c mice. In the pooled inoculum, the
dose of each individual mutant was therefore approximately
104 CFU. At 2 and 8 weeks postinfection, groups of three mice
were sacrificed. At necropsy, the only sign of disease evident
was enlargement of the spleen. To recover bacteria, spleens
were homogenized in PBS, and serial 10-fold dilutions were
plated on TSA-Km. After incubation for 4 days, bacteria were
resuspended from plates containing between 1,000 and 5,000
colonies, and chromosomal DNA was prepared from the re-
covered pool of mutants. Probes of input and output pools
were generated by PCR amplification of tags from chromo-
somal DNA of pooled ST mutants as described before (18) and
used for hybridization with dot blots containing individual mu-











tants in the corresponding pool. For each time point, a fresh
input pool probe was prepared and a blot was hybridized for
comparison with the output pools recovered from the mice.
We found that 39 mutants failed to give a reproducible hybrid-
ization signal when the input pool probe was prepared more
than once from a chromosomal DNA preparation. These mu-
tants were eliminated from the screen. Thus, a total of 178
mutants with consistently hybridizing tags were screened.
Mutants which gave weak or no hybridization signals on
output pool blots from at least two of the three mice at each
time point were identified as putatively attenuated by compar-
ison with input pool blots (Fig. 1). At 2 weeks postinfection, 28
mutants exhibited a reduction in the hybridization signal, sug-
gesting reduced recovery from the mouse spleens. Of these 28
mutants, 11 exhibited a reduced hybridization signal in output
pools recovered at 8 weeks postinfection.
In addition to the 11 mutants reduced in colonization at both
2 and 8 weeks, we identified 16 mutants that were only defec-
tive for colonization at 8 weeks. While mutants identified from
both the 2- and 8-week output pools may be unable to establish
infection, those identified only from the 8-week output pools
may be defective in sustaining chronic infection. The 17 mu-
tants identified only from the 2-week output pools may repre-
sent mutants which are slow to colonize the spleen but are still
able to persist. However, infection defects in these mutants
were not characterized further, since these mutants were able
to sustain chronic infection. Thus, two groups of mutants,
those identified at both 2 and 8 weeks and those identified only
FIG. 1. Colony blots showing hybridization of B. abortus ST mutants with probes containing tags amplified from the input pool and from output pools recovered
from spleens of three mice at 8 weeks postinfection. At the upper left and lower right corner of each blot is the parent stain, B. abortus 2308. Arrows indicate mutants
(BA142, BA152, BA159, and BA184 [left to right]) which gave weak signals in the output pools of at least two of the three mice inoculated and whose competitive
infection defect was confirmed subsequently. Open squares indicate mutants that gave inconsistent hybridization results and were therefore eliminated from the screen.











at 8 weeks, were considered putatively attenuated for chronic
infection and were chosen for further study (Table 1).
Competitive infection of mice with mutants identified by
STM. Following our identification of mutants putatively atten-
uated for chronic infection, we performed a quantitative assay
to confirm their colonization defect. To this end, each of the 27
mutants identified by the STM screen was inoculated i.p. at a
1:1 ratio with wild-type B. abortus at a total dose of approxi-
mately 105 CFU to groups of four mice (Table 1). As a control,
mutant BA53, which was recovered at both 2 and 8 weeks
postinfection from mice, was selected at random from the STM
pool as a negative control and administered to mice in a com-
petitive infection experiment as described above. During
mixed-infection experiments, 15 mutants identified in the STM
screen were found to have a significant defect in persistence in
mouse spleens. One of these mutants, BA11, had a significant
colonization defect only at 2 weeks and therefore was not
characterized further. Thus, for 14 of 27 mutants identified in
the preliminary STM screen, the putative chronic infection
defect could be confirmed by a significant reduction in coloni-
zation during competitive-infection experiments. Mutants
which did not have significant colonization defects in the com-
petitive-infection assay either may have been false-positives in
the STM screen or may only display competitive colonization
defects when inoculated at a wild type-to-mutant ratio of
greater than 1. However, these possibilities were not investi-
gated further. Mutants with significant colonization defects
during mixed infections fell into two groups: those reduced in
colonization at both 2 and 8 weeks, and those reduced at only
8 weeks (Fig. 2). Subsequent mouse infection experiments
showed that mutants with competitive colonization defects are
also attenuated when administered alone to mice (data not
shown). To determine whether colonization of the spleen was
reduced due to a general growth defect, mutants displaying
significant defects at both 2 and 8 weeks postinoculation were
assayed for in vitro growth defects by inoculating TSB with a
mixture of wild-type and ST mutant strains (Table 1). With the
exception of BA100, which was outgrown almost fivefold by the
parent strain, none of the mutants displayed a strong growth
deficiency in laboratory medium.
Identification of inactivated genes. Genes inactivated by
mini-Tn5Km2 insertions were identified by cloning transpo-
son-flanking DNA, sequence determination, and comparison
with the GenBank database using the BLAST2 search program
at NCBI. Transposon-flanking DNA was cloned from eight
mutants.
Mutants with defects in establishing chronic infection in-
cluded BA184, which carried a transposon insertion in a B.
abortus homologue of Brucella melitensis wbkA, encoding a
mannosyltransferase that functions in the biosynthesis of O
antigen (16). LPS biosynthesis is required for virulence in
Brucella species, and it has recently been shown that strains of
B. abortus and B. melitensis carrying defined mutations in genes
required for LPS biosynthesis are unable to establish infection
in mice (1, 16, 24). Identification of this known virulence factor
thus validated the STM screen.
Two additional mutants with defects in establishing persis-
tent infection, BA41 and BA114, carried transposon insertions
in homologues (virB1 and virB10, respectively) of the Brucella
suis virB locus (27). B. suis mutants carrying disruptions at this
locus show a reduced ability to multiply in vitro within macro-
phages and HeLa cells. Our data suggest that this locus is
required for establishing chronic infection in organs of the
mouse.
We could obtain no clone from DNA flanking the transpo-
son insertion of the fourth mutant (BA100) defective in estab-
lishing chronic infection. However, BA100 was unable to grow
on Brucella minimal medium unless supplemented with a com-
bination of aromatic amino acids. These auxanography data
indicated that this mutant was defective in an early step of the
aromatic amino acid biosynthesis pathway.
Sequences obtained from the transposon insertion site in
three mutants defective in sustaining chronic infection showed
homology to metabolic genes. BA159 was interrupted at the
gluP locus, encoding a putative transporter for glucose and
galactose (14). Mutant BA152 carried a transposon insertion in
a homologue of Rhizobium etli gltD, encoding the small subunit
of glutamate synthase (10). The identification of these two
mutants in the STM screen suggests that glucose, galactose, or
glutamate may serve as carbon and/or nitrogen sources during
growth of B. abortus in the host. BA102 carried an insertion in
a putative glycine dehydrogenase or glycine cleavage system.
Since BA102 did not have a competitive growth defect in TSA
and was able to grow on minimal medium without glycine, the
virulence defect of BA102 is likely not due to auxotrophy.
Interestingly, the activity of glycine dehydrogenase has been
shown to increase 10-fold upon entry of M. tuberculosis into a
state of nonreplicating persistence (30, 31). Since B. abortus,
like M. tuberculosis, is able to persist chronically in infected
FIG. 2. Mutants with statistically significant colonization defects, as con-
firmed by individual competitive infections and statistical analysis. Homologues
of disrupted genes are given in parentheses. nh, no homology.
TABLE 1. Confirmation of competitive defects of STM mutants by









2 wk 8 wk
BA11 2.29* 1.86 BA18 0.064
BA41 4.74* .29,512*** 0.97 BA27 2.24
BA73 3.36 147.9* 2.74 BA31 3.63*
BA87 1.08 10.47** 0.79 BA38 7.76*
BA100 20.89*** .758.6*** 4.70 BA63 1.86*
BA102 1.47 93.3*** 1.80 BA70 3.39
BA109 0.92 3.21 BA99 1.02
BA114 133.07** .1,047.1*** 0.91 BA105 2.00
BA157 0.74 1.58 BA119 6.31
BA159 1.50 23.44* 2.20 BA116 2.51






a Competitive index was calculated as [(CFUS2308/CFUmutant) recovered/
(CFUS2308/CFUmutant) inoculated]. Significant differences between competitive
indices of STM mutants and a control, nonattenuated mutant were compared
using a Student t test. p, P , 0.05; pp, P , 0.01; ppp, P , 0.005.











hosts, glycine dehydrogenase may play a similar role in the
entry of these pathogens into a latent state in the host.
Finally, DNA flanking two insertions in mutants defective
for maintaining chronic infection showed either no homology
to genes in the database (BA73) or homology to an open
reading frame of unknown function (BA87) (Table 2).
DISCUSSION
The goal of the STM screen was to identify and compare B.
abortus genes required for establishment and maintenance of
chronic persistence in the mouse. Since fewer than 200 genes
have been sequenced in Brucella species, we reasoned that
screening a small number of mutants would be sufficient to
identify new B. abortus genes required for chronic infection.
The STM screen identified 27 mutants putatively attenuated
for chronic infection. A statistically significant competitive-
infection defect could be detected in 14 of these mutants. Thus,
statistically significant evidence for attenuation was obtained
for 8% (14 of 178) of the mutants screened. Assuming that our
mutagenesis was random and that the coding density of the
3,200-kb B. abortus genome is similar to that of the E. coli
genome, our data suggest that an estimated 257 genes may be
required for establishing and maintaining chronic persistence
in mice after i.p. infection. In contrast, i.p. infection of mice
with an STM bank of Salmonella enterica Typhimurium re-
vealed that only 3% of its 4,400-kb genome, or an estimated
153 genes, is required for the acute infection caused by this
intracellular pathogen (18). The greater number of virulence
genes required for chronic infection versus acute disease may
reflect the requirement for additional adaptations to ensure
long-term persistence, such as those which prevent clearance
of B. abortus by the host immune system.
The working hypothesis of this study was that different sets
of genes may be required for the initial steps or the establish-
ment of chronic infection, which is characterized by rapid bac-
terial growth, than for maintenance of chronic infection, in
which little or no growth is observed (5, 9). Indeed, the 14
attenuated mutants identified in this study fell into two classes
(Fig. 2). Four mutants were unable to establish infection by
either 2 or 8 weeks postinfection. In contrast, the remaining 10
mutants were able to establish infection at 2 weeks postinfec-
tion but displayed a defect in chronic persistence at 8 weeks
postinfection. The first class included mutants with transpo-
son insertions in genes required for O antigen biosynthesis
(BA184), type IV secretion (BA41 and BA114), and biosyn-
thesis of aromatic amino acids (BA100). The genes inactivated
in these mutants are predicted to play a role early during
infection. For example, BA184, a wbkA mutant, was the most
highly attenuated and was outcompeted by the wild type by
1,000-fold at 2 weeks postinfection, suggesting that it was elim-
inated early in the infection process. Since rough mutants are
sensitive to the bactericidal action of complement, it is possible
that BA184 is cleared by complement-mediated lysis and may
reach the spleen only in small numbers (1, 11, 13). The trans-
poson insertion in BA100 rendered this mutant defective in the
biosynthesis of aromatic amino acids, as determined by aux-
anography. This biosynthesis pathway is also required for the
biosynthesis of 2,3-dihydroxybenzoic acid, the only siderophore
known to be produced by B. abortus (23). However, since this
siderophore has been shown to be dispensable for growth in
mice (7), it is more likely that attenuation of this mutant is the
result of its inability to acquire aromatic amino acids in the
host. Salmonella aro mutants are unable to survive and repli-
cate within macrophages and are attenuated for virulence (19).
Thus, some of the virulence genes required in an early phase
during chronic B. abortus infection may be similar to those
used by intracellular pathogens, such as S. enterica serovar
Typhimurium, which cause an acute infection. Two mutants
(BA114 and BA41) defective for initiation of chronic infection
carried insertions in a putative type IV secretion system of
B. abortus, encoded by the virB genes (27). Mutant BA114
(virB10) displayed a greater competitive colonization defect in
murine spleens at 2 weeks postinfection than BA41 (virB1)
(Table 1). A similar effect has been described for the homo-
logues of the B. abortus virB10 and virB1 genes present in the
genome of the plant pathogen Agrobacterium tumefaciens. In-
activation of virB1 in A. tumefaciens causes a lower degree of
attenuation than a mutation in virB10 (8). Mutations in the
virB locus render B. suis unable to multiply in HeLa cells or
macrophage cell lines in vitro (27). These data, together with
our findings that B. abortus virB1 and virB10 mutants are un-
able to persist in mouse spleens after i.p. inoculation, suggest
that attenuation in the animal model is due to an inability of
these strains to grow intracellularly.
The second class of mutants, which were unable to maintain
chronic infection, included strains defective in production of
glutamate synthase (BA152), glycine cleavage (BA102), nutri-
ent uptake (BA159), and several unknown functions (BA31,
BA38, BA73, BA87, BA63, BA122, and BA142). While the
inactivated genes in these mutants were not required for ini-
tiation of infection, they were required for chronic persistence.
Mutant BA102 carried a transposon insertion in a gene with
homology to gcvB, encoding glycine dehydrogenase, from M.
tuberculosis. The activity of this enzyme has been found to
increase 10-fold upon entry of M. tuberculosis into a state of
nonreplicating persistence in vitro (31). The finding that gly-
cine dehydrogenase is required for persistence of B. abortus in
the mouse spleen suggests that M. tuberculosis and B. abortus
may depend on similar metabolic pathways for chronic persis-
tence in the host. This result underscores the potential for
research on host pathogen interactions of B. abortus to eluci-
date mechanisms of intracellular persistence which are shared
by other chronic intracellular pathogens.
TABLE 2. Characterization of B. abortus genes identified by STM
Mutant Closest homologue (organism) GenBank accession no. Inferred function
BA41 virB1 (B. suis) AF141604 Type IV secretion
BA114 virB10 (B. suis) AF141604 Type IV secretion
BA184 wbkA (B. melitensis) AF047478 O antigen biosynthesis
BA159 gluP (B. abortus) U43785 Uptake of glucose and galactose
BA102 P protein (Synechocystis sp.) D90914 Glycine dehydrogenase
gcvB (M. tuberculosis) Q50601
BA152 gltD (R. etli) AF107264 Glutamate synthase
BA87 HP1225 (Helicobacter pylori) AE000628 Conserved inner membrane protein
BA73 No homology ?
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